Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin.

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

Challenging homografts as the holy grail for aortic valve endocarditis

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis Evaldas Girdauskas,

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Pulmonary hypertension in valve disease: A beast of the past?

Long-Term Follow-Up After Thoracoabdominal Aortic Aneurysm Repair

Form ever follows function

William M. DeCampli, MD, PhD

Bicuspid aortic valve aortopathy: One size fits all?

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Gastric conduit revision after esophagectomy: The raising of Lazarus

The variability of the mitral valve anatomy and terminology

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

The aortic valve–sparing operation

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Torsten Doenst, MD, PhD, Markus Richter, MD

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

The Journal of Thoracic and Cardiovascular Surgery

Which is the “lord” of the aortic rings?

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

The Mitroflow aortic valve: A past, present, and future illuminated

Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD

Warfarin or aspirin after mitral valve repair: Why work harder?

Hans-Joachim Schäfers, MD

Concomitant replacement of the ascending aorta is free—for some

First nights, the adrenal axis, and steroids

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Filip P Casselman, MD, M. Erwin S. H Tan, MD, Freddy E

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

The continuing challenge of congenital heart disease in China

Between a rock and a hard place

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

“The more things change…”: The challenges ahead

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Toward a more rational approach in treating type B aortic dissection

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Valve-sparing aortic root replacement in bicuspid aortic valves: A reasonable option? Diana Aicher, MD, Frank Langer, MD, Anke Kissinger, Henning Lausberg,

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Did you like Terminator 3 better than Terminator 2

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Journal changes and initiatives

Thanos Sioris, MD, Tirone E

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Deciding how much to pay for effective care

Presentation transcript:

Stentless biological valved conduit for aortic root replacement: Initial experience with the Shelhigh BioConduit model NR-2000C Abdullah Kaya, MD, Robin H. Heijmen, MD, PhD, J.C. Kelder, MD, Marc A. Schepens, MD, PhD, Wim J. Morshuis, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 5, Pages 1157-1162 (May 2011) DOI: 10.1016/j.jtcvs.2010.07.009 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Survival curve after aortic root replacement with a Shelhigh BioConduit for the elective, emergency, and total group. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1157-1162DOI: (10.1016/j.jtcvs.2010.07.009) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Freedom from reoperation after aortic root replacement with a Shelhigh BioConduit. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1157-1162DOI: (10.1016/j.jtcvs.2010.07.009) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions